Chart Check: This pharma company forms BAT pattern; target seen at Rs 1,000
[ad_1] rose a little over 2 per cent compared to about 7 per cent gain seen in the Nifty50 in the same period, but technical parameters suggest that the stock could see a bounce back towards Rs 1,000 levels in next 3-5 weeks, suggest experts. The pharma company with a market capitalisation of more than … Read more